Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

NXTC US Equity

NextCure, Inc.Health Care · Pharmaceutical Preparations · CIK 1661059 · FY ends Dec 31
$6.78
+0.13 (+1.95%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 5 13G
DateEventWhat happened / filerSource
2026-08-1513GSchedule 13G filed — ≥5% beneficial owner (passive) · by ADAR1 Capital Management, LLCsec.gov ↗
2026-08-1513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Ikarian Capital, LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Squadron Capital Management LLCsec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Affinity Asset Advisors, LLCsec.gov ↗
2026-08-1213GSchedule 13G filed — ≥5% beneficial owner (passive) · by Adage Capital Management, L.P.sec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-148-K 8.01Other eventssec.gov ↗
2026-07-148-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-148-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-148-K 5.01Changes in control of registrantsec.gov ↗
2026-07-148-K 2.05Costs associated with exit or disposal activities (restructuring)sec.gov ↗
2026-07-148-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-14

Every row is a filed document, checked against its EDGAR index.